Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute (THSTI), Faridabad, resigned from her position at the institute on Monday, multiple sources confirmed to The Hindu.
She has at least a year to go before her term comes to an end at the institute, an autonomous body under the Department of Biotechnology, Ministry of Science and Technology.
Dr. Kang (57) informed faculty members at the institute of her decision on Monday morning and has reportedly requested the Department of Biotechnology to relieve her by the end of August.
She is the first Indian woman to be elected as Fellow, Royal Society, London, and was instrumental in the development of Rotavac, the first vaccine to be made from scratch in India. Dr. Kang is also vice-chairperson, Coalition for Epidemic Preparedness, a global consortium involved with facilitating promising vaccine candidates for COVID-19.
She was the head of a group constituted by the Indian Council for Medical Research (ICMR) and the National COVID-19 taskforce to look at prospective indigenous vaccine candidates out of India. This group was however disbanded in a little over a month, as previously reported by The Hindu.
Dr. Kang is also Professor, Department of Gastrointestinal Sciences, Christian Medical College,Vellore. She was on lien from the institution and that tenure is to expire this August.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Faster pages
Move smoothly between articles as our pages load instantly.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Personalised recommendations
A select list of articles that match your interests and tastes.
Briefing
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
